Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Case Report: Adult-Onset Still’s Disease with Complications

Cristina Romaniello, DO, & Caitlin Kesari, MD  |  Issue: February 2023  |  February 14, 2023

The following report outlines a case of newly diagnosed adult-onset Still’s disease (AOSD) complicated by macrophage activation syndrome (MAS) in a previously healthy and active 32-year-old man who had emigrated from Africa to the U.S.

Case

A man with no prior medical history presented with acute-onset polyarthritis, fevers and fatigue that began one month previously. He had been seen in the emergency department several times and had multiple visits to his primary care doctor, who also noted elevated inflammatory markers.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In addition to the arthritis, he had developed a transient, diffuse rash and gross hematuria one week earlier. A review of systems also revealed sore throat, cough, pleuritic chest pain, muscle weakness, and an inability to walk. His symptoms were not relieved by ibuprofen.

On physical exam, the patient appeared ill, in mild distress and was sitting in a wheelchair. The patient had active synovitis, with notable red, hot, swollen joints in his fingers, knees, ankles and wrists. He had difficulty making a fist with both hands. The patient was prescribed 60 mg of prednisone daily and instructed to follow up in one week to review the results of his laboratory tests.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Laboratory results: elevated AST 170 U/L (normal range: 17–59 U/L), ALT 135 U/L (normal range: 0–57 U/L), albumin 3.2 g/dL (normal range: 3.5–5.0 g/dL) white blood cell count 23.2K/mcL (normal range: 4.5–11K/mcL) with 96% polymorphonuclear neutrophils (PMN), erythrocyte sedimentation rate (ESR) 37 mm/hr (normal range: 0–15 mm/hr), C-reactive protein (CRP) 328.2 mg/L (normal range <10 mg/L). Most notably, ferritin was significantly elevated at 20,853.3 ng/mL (normal range: 3.8–10.6 ng/mL).

Due to these markedly abnormal lab results and lack of improvement with high-dose glucocorticoids, the patient was directly admitted to the hospital for further evaluation. Specialists in infectious disease, rheumatology, oncology and orthopedic surgery followed this patient during his hospitalization.

Extensive infectious disease testing was performed, ruling out SARS-CoV-2, hepatitis B, hepatitis C, HIV, cytomegalovirus, Epstein-Barr virus, parvovirus B-19, influenza, malaria, histoplasmosis and tuberculosis. Blood and urine cultures were negative. Uric acid levels, rheumatoid factor and antistreptolysin O antibodies were within normal limits. Chest X-ray, computed tomography (CT) of the chest, abdomen and pelvis, and magnetic resonance imaging (MRI) of the cervical, thoracic and lumbar spine revealed no acute pathology, signs of infection or masses. Transthoracic echocardiogram was negative for valvular vegetation.

On hospital day 3, synovial fluid analysis of the left knee revealed some calcium pyrophosphate crystals.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:ConditionsOther Rheumatic Conditions Tagged with:adult Still's Diseasecase reportmacrophage activation syndrome

Related Articles

    Macrophage Activation Syndrome

    December 1, 2010

    A review of diagnosis, treatment, and prognosis

    New Criteria Released for Macrophage Activation Syndrome in Juvenile Idiopathic Arthritis

    August 10, 2016

    Although most systemic juvenile idiopathic arthritis patients don’t develop macrophage activation syndrome (MAS), the approximately 10% who do have this serious complication can experience widespread, massive inflammation, debilitating symptoms and even death. To improve understanding of MAS among physicians and advance efforts to develop effective therapies to treat it, a panel of 28 international pediatric…

    2014 ACR/ARHP Annual Meeting: Macrophage Activation Syndrome

    April 1, 2015

    The pathogenesis of and new classification criteria for MAS

    Case Report: Intermittent Fevers in a Patient with pJIA

    April 15, 2022

    A 26-year-old woman presented to our emergency department (ED) with intermittent fevers, nausea and vomiting. She had a past medical history of well-controlled, anti-nuclear antibody positive and rheumatoid factor negative polyarticular juvenile idiopathic arthritis (pJIA) and Crohn’s disease. Her maintenance treatment consisted of monthly intravenous infliximab, 10 mg of oral methotrexate weekly and 20 mg…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences